Your browser doesn't support javascript.
loading
Structural Insights into Plasticity and Discovery of Remdesivir Metabolite GS-441524 Binding in SARS-CoV-2 Macrodomain.
Ni, Xiaomin; Schröder, Martin; Olieric, Vincent; Sharpe, May E; Hernandez-Olmos, Victor; Proschak, Ewgenij; Merk, Daniel; Knapp, Stefan; Chaikuad, Apirat.
Afiliación
  • Ni X; Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, 60438 Frankfurt am Main, Germany.
  • Schröder M; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, 60438 Frankfurt am Main, Germany.
  • Olieric V; Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, 60438 Frankfurt am Main, Germany.
  • Sharpe ME; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, 60438 Frankfurt am Main, Germany.
  • Hernandez-Olmos V; Swiss Light Source, Paul Scherrer Institute, 5232 Villigen, Switzerland.
  • Proschak E; Swiss Light Source, Paul Scherrer Institute, 5232 Villigen, Switzerland.
  • Merk D; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596 Frankfurt, Germany.
  • Knapp S; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, 60438 Frankfurt am Main, Germany.
  • Chaikuad A; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596 Frankfurt, Germany.
ACS Med Chem Lett ; 12(4): 603-609, 2021 Apr 08.
Article en En | MEDLINE | ID: mdl-33850605
ABSTRACT
The nsP3 macrodomain is a conserved protein interaction module that plays essential regulatory roles in the host immune response by recognizing and removing posttranslational ADP-ribosylation sites during SARS-CoV-2 infection. Thus targeting this protein domain may offer a therapeutic strategy to combat current and future virus pandemics. To assist inhibitor development efforts, we report here a comprehensive set of macrodomain crystal structures complexed with diverse naturally occurring nucleotides, small molecules, and nucleotide analogues including GS-441524 and its phosphorylated analogue, active metabolites of remdesivir. The presented data strengthen our understanding of the SARS-CoV-2 macrodomain structural plasticity and provide chemical starting points for future inhibitor development.